| 1 | PPP1R1B, TRA2B
|
| DARPP-32 binds to tra2-beta1 and influences alternative splicing.
|
| Benderska N, Becker K, Girault JA, Becker CM, Andreadis A, Stamm S.
|
| Biochim Biophys Acta 1799(5-6):448-53. doi: 10.1016/j.bbagrm.2010.01.003. Epub 2010 Jan 13.
2010
|
| 2 | PPP1R1B
|
| t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanism.
|
| Belkhiri A, Dar AA, Zaika A, Kelley M, El-Rifai W.
|
| Cancer Res 68(2):395-403. 2008
|
| 3 | PPP1R1B
|
| A phosphatase cascade by which rewarding stimuli control nucleosomal response.
|
| Stipanovich A, Valjent E, Matamales M, Nishi A, Ahn JH, Maroteaux M, Bertran-Gonzalez J, Brami-Cherrier K, Enslen H, CorbillŽ AG, Filhol O, Nairn AC, Greengard P, HervŽ D, Girault JA.
|
| Nature 453(7197):879-84. Epub 2008 May 21. 2008
|
| 4 | PPP1R1B
|
| Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs.
|
| Bateup HS, Svenningsson P, Kuroiwa M, Gong S, Nishi A, Heintz N, Greengard P.
|
| Nat Neurosci 11(8):932-9. Epub 2008 Jul 11.
2008
|
| 5 | PPP1R1B
|
| Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition.
|
| Meyer-Lindenberg A, Straub RE, Lipska BK, Verchinski BA, Goldberg T, Callicott JH, Egan MF, Huffaker SS, Mattay VS, Kolachana B, Kleinman JE, Weinberger DR.
|
| J Clin Invest 117(3):672-82. Epub 2007 Feb 8.
2007
|
| 6 | PPP1R1B, ZNRD1
|
| DARPP-32 mediates multidrug resistance of gastric cancer through regulation of P-gp and ZNRD1.
|
| Hong L, Wang J, Zhao Y, Han Z, Zhou X, Guo W, Zhang X, Jin H, Wu K, Ding J, Fan D.
|
| Cancer Invest 25(8):699-705.PMID: 18058465 2007
|
| 7 | PPP1R1B
|
| Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades.
|
| Nishi A, Watanabe Y, Higashi H, Tanaka M, Nairn AC, Greengard P.
|
| Proc Natl Acad Sci U S A 102(4):1199-204. Epub 2005 Jan 18. 2005
|
| 8 | PPP1R1B
|
| Overexpression of the 32-kilodalton dopamine and cyclic adenosine 3',5'-monophosphate-regulated phosphoprotein in common adenocarcinomas.
|
| Beckler A, Moskaluk CA, Zaika A, Hampton GM, Powell SM, Frierson HF Jr, El-Rifai W.
|
| Cancer 98(7):1547-51. 2003
|
| 9 | PPP1R1B
|
| Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP.
|
| El-Rifai W, Smith MF Jr, Li G, Beckler A, Carl VS, Montgomery E, Knuutila S, Moskaluk CA, Frierson HF Jr, Powell SM.
|
| Cancer Res 62(14):4061-4. 2002
|
| 10 | PPP1R1B
|
| Requirement for DARPP-32 in progesterone-facilitated sexual receptivity in female rats and mice.
|
| Mani SK, Fienberg AA, O'Callaghan JP, Snyder GL, Allen PB, Dash PK, Moore AN, Mitchell AJ, Bibb J, Greengard P, O'Malley BW.
|
| Science 287(5455):1053-6. 2000
|
| 11 | CDK5, PPP1R1B
|
| Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.
|
| Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, Tsai LH, Kwon YT, Girault JA, Czernik AJ, Huganir RL, Hemmings HC Jr, Nairn AC, Greengard P.
|
| Nature 402(6762):669-71. 1999
|
| 12 | PPP1R1B
|
| Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade.
|
| Greengard P, Allen PB, Nairn AC.
|
| Neuron 23(3):435-47. Review. No abstract available. 1999
|
| 13 | PPP1R1B
|
| DARPP-32: regulator of the efficacy of dopaminergic neurotransmission.
|
| Fienberg AA, Hiroi N, Mermelstein PG, Song W, Snyder GL, Nishi A, Cheramy A, O'Callaghan JP, Miller DB, Cole DG, Corbett R, Haile CN, Cooper DC, Onn SP, Grace AA, Ouimet CC, White FJ, Hyman SE, Surmeier DJ, Girault J, Nestler EJ, Greengard P.
|
| Science 281(5378):838-42. 1998
|
| 14 | ARPP19, ARPP21, PPP1R1B
|
| Expression of mRNAs encoding ARPP-16/19, ARPP-21, and DARPP-32 in human brain tissue.
|
| Brene S, Lindefors N, Ehrlich M, Taubes T, Horiuchi A, Kopp J, Hall H, Sedvall G, Greengard P, Persson H.
|
| J Neurosci 14(3 Pt 1):985-98. 1994
|
| 15 | PPP1R1B
|
| Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices.
|
| Halpain S, Girault JA, Greengard P.
|
| Nature 343(6256):369-72. 1990
|
| 16 | PPP1R1B
|
| DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1.
|
| Hemmings HC Jr, Greengard P, Tung HY, Cohen P.
|
| Nature 310(5977):503-5. 1984
|